Edition:
United States

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

157.20SEK
12:00pm EDT
Change (% chg)

1.60kr (+1.03%)
Prev Close
155.60kr
Open
159.40kr
Day's High
159.40kr
Day's Low
154.00kr
Volume
172,931
Avg. Vol
122,257
52-wk High
161.00kr
52-wk Low
53.25kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Earnings (per share)
Year Ending Dec-18 2 -6.75 -6.26 -7.24 -6.61
Year Ending Dec-19 2 -5.82 -5.75 -5.88 -5.28
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 241.68 34.14
P/E High - Last 5 Yrs. -- 292.11 47.66
P/E Low - Last 5 Yrs. -- 101.47 25.16
Beta -- 0.73 0.78
Price to Sales (TTM) -- 277.62 8.57
Price to Book (MRQ) 10.45 23.87 4.34
Price to Tangible Book (MRQ) 10.05 31.36 6.03
Price to Cash Flow (TTM) -- 141.06 22.77
% Owned Institutions -- 10.76 2.40

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.24 -6.55
Payout Ratio(TTM) -- 42.12 39.30

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 24.41 5.00
Sales (TTM) vs TTM 1 Yr. Ago -- 137.83 12.49
Sales - 5 Yr. Growth Rate -- 30.90 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago 11.40 -77.62 40.62
EPS (TTM) vs TTM 1 Yr. Ago -7.20 -- --
EPS - 5 Yr. Growth Rate -- 48.46 8.03
Capital Spending - 5 Yr. Growth Rate -- 36.24 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.56
Current Ratio (MRQ) 8.79 6.36 3.64
LT Debt to Equity (MRQ) 0.00 20.82 12.92
Total Debt to Equity (MRQ) 0.00 25.13 17.37
Interest Coverage (TTM) -- -141.93 35.98

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.43 54.96
Gross Margin - 5 Yr. Avg. -- 54.95 52.86
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -171.02 15.70
Operating Margin (TTM) -- -947.27 -0.77
Operating Margin - 5 Yr. Avg. -- -184.72 10.94
Pre-Tax Margin (TTM) -- -830.61 1.31
Pre-Tax Margin - 5 Yr. Avg. -- -188.11 11.12
Net Profit Margin (TTM) -- -823.71 -1.98
Net Profit Margin - 5 Yr. Avg. -- -186.54 7.48
Effective Tax Rate (TTM) -- 15.15 29.95
Effective Tax Rate - 5 Yr. Avg. -- 19.20 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,782,551 736,570,410
Net Income/Employee (TTM) -9,169,222 -431,793 85,786,139
Receivable Turnover (TTM) -- 18.21 6.05
Inventory Turnover (TTM) -- 2.86 3.65
Asset Turnover (TTM) 0.00 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.61 -4.01 10.37
Return on Assets - 5 Yr. Avg. -- -1.12 11.08
Return on Investment (TTM) -39.32 -5.91 13.17
Return on Investment - 5 Yr. Avg. -- 1.60 14.39
Return on Equity (TTM) -39.42 -7.75 15.14
Return on Equity - 5 Yr. Avg. -- -3.78 15.73
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -38.98 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oncopeptides AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 37.94 41.96 99 76
13 Week 83.71 79.25 99 28
26 Week 77.83 78.34 99 83
52 Week 194.98 202.46 99 85
YTD 94.50 91.65 99 80
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.09%
# of Holders: 23
Total Shares Held: 35,943,499
3 Mo. Net Change: 1,983,229
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 15
# Reduced Positions: 4
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.